Less Ads, More Data, More Tools Register for FREE

Pin to quick picksConduit Hldg Regulatory News (CRE)

Share Price Information for Conduit Hldg (CRE)

Share Price is delayed by 15 minutes
Get Live Data
445.00    8.50 (1.95%)
Bid:
444.50
Ask:
445.00
Spread: 0.50 (0.112%)
Market Cap: £658.17m
CRE Live PriceLast checked at - London Stock Exchange

Intraday Conduit Hldg Share Chart

Interim Management Statement

14 Aug 2009 07:00

RNS Number : 4266X
Creston PLC
14 August 2009
 



Press Release  14 August 2009

Creston plc 

Interim Management Statement 

Creston plc (LSE: CRE), the Insight and Communications Group, announces its interim management statement for the period 1 April 2009 to 30 July 2009.

Trading

The Group's trading overall remains in line with management's expectations. After a robust performance in our last financial year, which saw like-for-like revenue growth in each quarter and 4 per cent for the full year, the prevailing economic recession has caused an anticipated decline and re-phasing of marketing budgets for some clients during the first quarter of the new financial year. The Group has reported a like-for-like revenue decline of 6 per cent for the first quarter compared with the particularly strong first quarter growth of 5 per cent last year. 

The Insight Division had its highest level of secured commissions by this point in the year. The Communications Division has been effected by the expected client budget cuts, however, this has been partly offset by the new business wins from last year. The Health Division's growth has been driven by the new medical education and international offers and their continuing excellent performance in new business.

Although the current economic climate is having an effect on client budgets, we continue to win new business to offset the impact. New business wins to date include Astellas, Astra Zeneca, BMW Motorrad, COI (blood and transplant and vulnerable workers), E-on, GSK and Saudi Arabian General Investment Authority plus other major wins yet to be announced. The new business pipeline remains strong and with a historical high pitch to win ratio, we are confident of winning a good proportion of the opportunities. 

Balance Sheet

On 7 July 2009 the Company successfully raised £3.3m (gross) through a limited capital raising from long term shareholders. The fundraising provides additional working capital for the Group, and also allows for investment in our organic growth plans in areas such as mobile and digital healthcare marketing.

The Group continues to manage its working capital effectively and has generated operating cash flow in line with the Board's expectations. 

Outlook

Despite the current economic climate we believe that the Group's new divisional structure and the new business pipeline stand the Group in good stead for the full year. 

For further information, please contact:

Creston plc

020 7930 9757

Don Elgie, Chief Executive

Barrie Brien, COO/CFO

www.creston.com 

Hogarth Partnership Limited

020 7357 9477

Chris Matthews/Fiona Noblet/Anthony Arthur

 

About Creston plc

Creston is an Insight and Communications company for the 21st century. It offers clients more seamless access to the most innovative marketing insights and communications services to help grow their brands in a rapidly-changing consumer world. Our companies draw upon the collective knowledge, expertise and services from across-the-Group, so that their clients receive the best advice and achieve the best results no matter what the medium. By working together, whether on research or as full-scale marketing partners, our companies continuously innovate to make more things possible for their clients and people.

Creston companies offer a range of marketing services, such as advertising, direct and digital marketing, market research, public relations and healthcare marketing to a broad range of blue-chip clients including: Amazon, AstraZeneca, Aviva, Bayer, BMW, BT, Burger King, Canon, COI Communications, Cow & Gate, Daily Mirror, Diageo, E-on, First Direct, GlaxoSmithKline, Halifax, Homeform, House of Fraser, Kimberly-Clark, Lexus, Lloyds Black Horse, Morrisons, NHS Lottery, Nissan, Opel, Pfizer, Roche Diagnostics, Royal Mail, SAB Miller, Sainsbury's, Tesco, Thorpe Park, Toshiba, Trinity Mirror, T-Mobile, Tropicana, Unilever, Vauxhall, Vodafone, Walkers and WH Smith.

Creston's share price is quoted in the Financial Times, The Daily Telegraph, The Times and the London Evening Standard.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSEAKPDFEXNEFE
Date   Source Headline
9th Jun 20267:00 amRNSTransaction in Own Shares
2nd Jun 20267:00 amRNSTransaction in Own Shares
26th May 20262:53 pmRNS$50 million Share Buyback Programme
20th May 20267:00 amRNSHolding(s) in Company
19th May 20267:00 amRNSTransaction in Own Shares
15th May 20267:00 amRNSHolding(s) in Company
14th May 20267:00 amRNSResult of AGM
13th May 20267:00 amRNSTrading Update for Q1 2026
12th May 20267:00 amRNSTransaction in Own Shares
5th May 20267:00 amRNSTransaction in Own Shares
28th Apr 20267:00 amRNSNotice of Q1 2026 Trading Update
28th Apr 20267:00 amRNSDirectorate change
28th Apr 20267:00 amRNSTransaction in Own Shares
23rd Apr 20267:00 amRNSHolding(s) in Company
21st Apr 20267:00 amRNSTransaction in Own Shares
15th Apr 20264:54 pmRNSDirector/PDMR Shareholding
10th Apr 20264:26 pmRNSHolding(s) in Company
10th Apr 20267:00 amRNSTransaction in Own Shares
9th Apr 20267:00 amRNSTransaction in Own Shares
8th Apr 20265:56 pmRNSNotice of AGM
8th Apr 20267:00 amRNSTransaction in Own Shares
7th Apr 20267:00 amRNSTransaction in Own Shares
2nd Apr 20267:00 amRNSTransaction in Own Shares
1st Apr 20267:00 amRNSHolding(s) in Company
30th Mar 20265:27 pmRNSDirector/PDMR Shareholding
30th Mar 20265:26 pmRNSDirector/PDMR Shareholding
30th Mar 20265:26 pmRNSDirector/PDMR Shareholding
30th Mar 20265:26 pmRNSDirector/PDMR Shareholding
27th Mar 20267:00 amRNSDirectorate change
27th Mar 20267:00 amRNSTransaction in Own Shares
26th Mar 20267:00 amRNSTransaction in Own Shares
25th Mar 20267:00 amRNSDirector/PDMR Shareholding
25th Mar 20267:00 amRNSTransaction in Own Shares
24th Mar 20267:00 amRNSTransaction in Own Shares
23rd Mar 20267:00 amRNSTransaction in Own Shares
20th Mar 20267:00 amRNSTransaction in Own Shares
19th Mar 20267:00 amRNSTransaction in Own Shares
18th Mar 20267:00 amRNSTransaction in Own Shares
17th Mar 20267:00 amRNSTransaction in Own Shares
17th Mar 20267:00 amRNSTransaction in Own Shares
16th Mar 20267:00 amRNSTransaction in Own Shares
16th Mar 20267:00 amRNSTransaction in Own Shares
13th Mar 20267:00 amRNSTransaction in Own Shares
13th Mar 20267:00 amRNSTransaction in Own Shares
12th Mar 20267:00 amRNSTransaction in Own Shares
11th Mar 20263:06 pmRNSDirectorate change
11th Mar 20267:00 amRNSTransaction in Own Shares
10th Mar 20267:00 amRNSTransaction in Own Shares
9th Mar 20267:00 amRNSPDMR Notification
9th Mar 20267:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.